Evolution Therapy
Latest round
- Angel
Last raised
- May 2026
Total raised
- Undisclosed
Investors
- 2
About Evolution Therapy
, dba Evolution Therapy, operates as a biotechnology company that focuses on providing cross-species oncology gene therapy services. Peng Du, the founder of the company, graduated from Harvard Medical School and served as a researcher and associate professor in the School of Life Sciences at Peking University. He was awarded the National Outstanding Youth Science Foundation. The company has completed the industrialization landing project in Zibo. Evolution Therapy's main business is the research and development of a gene therapy platform based on plant immune protein-mediated gene therapy. It developed the plant RDR1 protein-mediated miRNA repair therapy, which is able to become a broad-spectrum antitumor method for multiple cancer indications. The protein-mediated miRNA repair therapy can be used in the treatment of relapsed and refractory cancers. The company generates revenue by providing plant RDR1 protein-mediated miRNA repair therapy.
Who invested in Evolution Therapy
2 investors across 2 rounds
See all investors in Evolution Therapy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evolution Therapy
Who invested in Evolution Therapy?
Evolution Therapy has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evolution Therapy raised?
Evolution Therapy has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Evolution Therapy last raise money?
Evolution Therapy's most recent round on record is a Angel, in May 2026.
What does Evolution Therapy do?
, dba Evolution Therapy, operates as a biotechnology company that focuses on providing cross-species oncology gene therapy services.
Where is Evolution Therapy headquartered?
Evolution Therapy is headquartered in Beijing, China.
Which VCs invest in companies like Evolution Therapy?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Evolution Therapy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Evolution Therapy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.